Immediate Impact
2 by Nobel laureates 8 from Science/Nature 55 standout
Citing Papers
Oesophageal cancer
2024 Standout
Theranostic Fluorescent Probes
2024 Standout
Works of Stephen Broderick being referenced
Abstract CT003: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as neoadjuvant treatment (tx) for resectable (IB-IIIA) non-small cell lung cancer (NSCLC) in the phase 3 CheckMate 816 trial
2021
Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC).
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Stephen Broderick | 1939 | 725 | 1026 | 81 | 2.6k | |
| Lin Gu | 1673 | 485 | 1000 | 100 | 2.7k | |
| Noriyoshi Sawabata | 2545 | 763 | 1096 | 179 | 3.6k | |
| Willard A. Fry | 2644 | 890 | 1056 | 48 | 3.4k | |
| A. Aupérin | 1238 | 819 | 1184 | 74 | 3.1k | |
| Dominique Grunenwald | 2103 | 739 | 1284 | 86 | 3.3k | |
| Masashi Wakabayashi | 1775 | 774 | 1321 | 130 | 3.0k | |
| Jason A. Zell | 1663 | 622 | 1915 | 128 | 3.6k | |
| Gavin Wright | 2035 | 361 | 1250 | 126 | 2.9k | |
| Raymond P. Abratt | 1402 | 363 | 1302 | 81 | 2.4k | |
| Jae Ill Zo | 2417 | 848 | 603 | 111 | 3.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...